p.48 抽出テキスト
3.0 3.2 3.4 3.4 3.0 3.1 3.2 3.3 3.0 3.1 3.3 3.4 3.1 3.2 3.3 3.4 2.1 2.3 2.4 2.5 2.1 2.2 2.3 2.3 2.0 2.2 2.3 2.4 2.1 2.2 2.4 2.4 0.8 0.8 0.9 0.9 1.6 1.7 1.9 1.9 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 1.7 1.7 1.8 1.8 1.8 1.8 1.8 1.8 1.7 1.8 1.9 1.9 2.2 2.3 2.5 2.5 2.2 2.3 2.4 2.5 2.0 2.3 2.4 2.4 3.0 2.6 2.8 2.9 2.2 2.4 2.5 2.5 2.6 2.7 2.9 3.0 2.6 2.7 2.9 3.0 2.6 2.7 2.9 2.8 0.5 0.5 0.5 0.6 0.7 0.9 0.9 1.0 0.5 0.7 0.7 0.7 0.5 0.6 0.6 0.7 0.5 0.5 0.6 0.6 0.8 1.0 1.0 1.1 0.8 0.9 1.0 1.1 0.8 0.9 1.0 1.0 1.2 1.3 1.4 1.5 1.2 1.3 1.4 1.4 1.2 1.3 1.4 1.4 1.9 1.6 1.7 1.9 1.2 1.3 1.4 1.5 1.7 1.8 1.9 1.9 1.6 1.8 1.9 2.0 1.7 1.8 1.9 1.9 160-179 140-159 120-139 100-119 160-179 140-159 120-139 100-119 160-179 140-159 120-139 100-119 160-179 140-159 120-139 100-119 160-179 140-159 120-139 100-119 90+ 85-89 80-84 75-79 70-74 Systolic blood pressure (mmHg) Age (y) LIFE-CVD model CVD-free lifetime gain from smoking cessation (in years) Non-HDL cholesterol Women Men mmol/L 150 200 250 mg/dL 1.0 - 1.4 years 1.5 - 2.0 years 3.0-3.9 4.0-4.9 5.0-5.9 6.0-6.9 150 200 250 3.0-3.9 4.0-4.9 5.0-5.9 6.0-6.9 < 0.5 years 0.5 - 0.9 years ≥2.0 years 4.2 4.4 4.6 4.7 3.9 4.0 4.2 4.3 3.8 3.6 3.6 3.8 3.9 3.3 3.5 3.6 3.7 3.4 3.6 3.7 3.8 3.4 3.6 3.9 4.1 4.3 4.5 4.6 3.6 3.6 3.8 3.9 3.6 3.7 4.0 4.0 3.7 3.9 4.1 4.2 3.7 4.0 4.1 4.3 3.8 3.9 4.0 4.1 4.2 4.4 4.6 4.7 4.3 4.5 4.8 4.9 3.9 4.0 4.3 4.3 4.0 4.2 4.4 4.5 4.5 4.7 5.0 5.1 4.1 4.2 4.4 4.5 4.4 4.5 4.8 4.9 4.1 4.3 4.4 4.5 3.3 3.4 3.6 3.7 2.9 3.1 3.2 3.3 2.9 2.7 2.7 2.9 2.9 2.4 2.6 2.7 2.7 2.5 2.7 2.8 2.8 2.6 2.7 2.9 3.3 3.5 3.7 3.8 2.7 2.7 2.9 2.9 2.8 2.9 3.0 3.1 2.9 3.0 3.2 3.3 3.0 3.1 3.3 3.4 2.8 3.0 3.1 3.2 3.3 3.5 3.7 3.9 3.5 3.7 3.9 4.2 2.9 3.1 3.3 3.4 3.1 3.2 3.5 3.6 3.7 3.9 4.2 4.4 3.1 3.2 3.3 3.5 3.4 3.7 3.9 4.1 3.1 3.3 3.4 3.6 4.1 4.3 4.5 4.5 4.3 4.5 4.6 4.8 4.4 4.6 4.9 5.0 4.5 4.8 5.1 5.2 3.2 3.3 3.4 3.6 3.3 3.5 3.7 3.9 3.5 3.7 4.0 4.2 3.7 4.0 4.3 4.5 160-179 140-159 120-139 100-119 160-179 140-159 120-139 100-119 160-179 140-159 120-139 100-119 160-179 140-159 120-139 100-119 160-179 140-159 120-139 100-119 65-69 60-64 55-59 50-54 45-49 160-179 140-159 120-139 100-119 40-44 Figure 11 Lifetime atherosclerotic cardiovascular disease benefit from smoking cessation for apparently healthy persons, based on the following risk factors: age, sex, systolic blood pressure, and non-high-density lipoprotein-cholesterol. The model is currently validated for low- and moderate-risk countries. CVD = cardiovascular disease; ESC = European Society of Cardiology; HDL-C = high-density lipoprotein cholesterol; HR = hazard ratio; LIFE-CVD = LIFEtime-perspective CardioVascular Disease; SBP = systolic blood pressure. The lifetime benefit is expressed as ‘years of median life expectancy free from myocardial infarction or stroke’ gained from smoking cessation. The lifetime benefit is calculated by estimating lifetime CVD risk with the LIFE-CVD model76 multiplied by the HR compared to sustained smoking (0.60) from a meta-analysis of studies on the CVD risk of smoking496 and multiplied by the HR (0.73) for non-CVD competing mortality.497 For individualized estimations of lifetime benefit, this table can be used or the electronic version of LIFE- CVD, assessable via the ESC CVD risk app or https://u-prevent.com/. Downloaded from academic.oup.com/eurheartj/article/42/34/3227/6358713 by guest on 07 October 2026